tiprankstipranks
Bluebird Bio Faces Nasdaq Compliance Challenge and Delays
PremiumCompany AnnouncementsBluebird Bio Faces Nasdaq Compliance Challenge and Delays
26d ago
Bluebird Bio receives expected notice from Nasdaq
PremiumThe Fly
Bluebird Bio receives expected notice from Nasdaq
26d ago
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
PremiumStock Analysis & Ideas
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
1M ago
Options Volatility and Implied Earnings Moves Today, March 26, 2024
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 26, 2024
2M ago
Bluebird Bio reports Q4 revenue $7.8M, consensus $16.68M	.
PremiumThe Fly
Bluebird Bio reports Q4 revenue $7.8M, consensus $16.68M .
2M ago
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
PremiumThe Fly
Bluebird Bio price target lowered to $1.68 from $3 at Wedbush
2M ago
Short Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt
PremiumThe FlyShort Report: Bears boost exposure to Rocket Companies despite dovish Fed tilt
5M ago
Bluebird Bio price target lowered to $5 from $12 at BofA
PremiumThe Fly
Bluebird Bio price target lowered to $5 from $12 at BofA
5M ago
Bluebird Bio 83.33M share Secondary priced at $1.50
PremiumThe Fly
Bluebird Bio 83.33M share Secondary priced at $1.50
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100